Wuhan Keqian Biology Co.,Ltd (SHA:688526)
China · Delayed Price · Currency is CNY 12.38
+0.29 (2.40%)
Jun 23, 2026, 3:00 PM CST
SHA:688526 Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, SHA:688526 stock has a consensus rating of "Strong Buy" and an average price target of ¥18.50. The average 1-year stock price forecast is 49.43% higher than the current stock price, while the lowest is ¥18.00 (+45.40%) and the highest is ¥19.00 (+53.47%).
Price Target: ¥18.50 (+49.43%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SHA:688526 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Dec '25 | Jan '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 4 | 3 | 2 |
| Buy | 0 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 5 | 4 | 2 |
Financial Forecast
Revenue This Year
1.09B
from 949.74M
Increased by 14.87%
Revenue Next Year
1.27B
from 1.09B
Increased by 16.84%
EPS This Year
0.93
from 0.76
Increased by 22.37%
EPS Next Year
1.13
from 0.93
Increased by 21.51%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.2B | ||
| Avg | 1.1B | ||
| Low | 1.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 23.8% | ||
| Avg | 14.9% | ||
| Low | 5.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 0.93 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 22.4% | ||
| Low | - |